This federal contract award, valued at $4,665.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product.
The contract is a Delivery Order, with a Firm Fixed Price pricing type, and no set-aside designation. It is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The contract will run through December 31, 2024, and represents one of many federal contract awards held by AmerisourceBergen, demonstrating the company's broad capabilities in supplying a variety of pharmaceutical and medical products to various government agencies, particularly within the Defense and Veterans' Affairs healthcare systems.
Generated 3/31/25, 9:37 AM